Click for best price
Cancer Biological Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Cancer Biological Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biological Therapy. This report contains market size and forecasts of Cancer Biological Therapy in global, including the following market information:
Global Cancer Biological Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Biological Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Biological Therapy include ELI Lilly, Sanofi, Merck, Bayer, Roche, Novartis International, Pfizer, Bristol-Myers Squibb and Seattle Genetics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Biological Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Biological Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biological Therapy Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Global Cancer Biological Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biological Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Global Cancer Biological Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Biological Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Biological Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Biological Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biological Therapy, market overview.
Chapter 2: Global Cancer Biological Therapy market size in revenue.
Chapter 3: Detailed analysis of Cancer Biological Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biological Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Biological Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Biological Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Biological Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Biological Therapy Overall Market Size
2.1 Global Cancer Biological Therapy Market Size: 2022 VS 2029
2.2 Global Cancer Biological Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Biological Therapy Players in Global Market
3.2 Top Global Cancer Biological Therapy Companies Ranked by Revenue
3.3 Global Cancer Biological Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biological Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Biological Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biological Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Biological Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Biological Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Biological Therapy Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Vaccines
4.1.4 Cancer Growth Blockers
4.1.5 Blood Cell Growth Factors
4.2 By Type - Global Cancer Biological Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Biological Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Biological Therapy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Biological Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Research & Academic Laboratories
5.1.5 Pharmaceutical & Biotechnology Companies
5.2 By Application - Global Cancer Biological Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Biological Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Biological Therapy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Biological Therapy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Biological Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Biological Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Biological Therapy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Biological Therapy Revenue, 2018-2029
6.3.2 US Cancer Biological Therapy Market Size, 2018-2029
6.3.3 Canada Cancer Biological Therapy Market Size, 2018-2029
6.3.4 Mexico Cancer Biological Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Biological Therapy Revenue, 2018-2029
6.4.2 Germany Cancer Biological Therapy Market Size, 2018-2029
6.4.3 France Cancer Biological Therapy Market Size, 2018-2029
6.4.4 U.K. Cancer Biological Therapy Market Size, 2018-2029
6.4.5 Italy Cancer Biological Therapy Market Size, 2018-2029
6.4.6 Russia Cancer Biological Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Biological Therapy Market Size, 2018-2029
6.4.8 Benelux Cancer Biological Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Biological Therapy Revenue, 2018-2029
6.5.2 China Cancer Biological Therapy Market Size, 2018-2029
6.5.3 Japan Cancer Biological Therapy Market Size, 2018-2029
6.5.4 South Korea Cancer Biological Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Biological Therapy Market Size, 2018-2029
6.5.6 India Cancer Biological Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Biological Therapy Revenue, 2018-2029
6.6.2 Brazil Cancer Biological Therapy Market Size, 2018-2029
6.6.3 Argentina Cancer Biological Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Biological Therapy Revenue, 2018-2029
6.7.2 Turkey Cancer Biological Therapy Market Size, 2018-2029
6.7.3 Israel Cancer Biological Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Biological Therapy Market Size, 2018-2029
6.7.5 UAE Cancer Biological Therapy Market Size, 2018-2029
7 Cancer Biological Therapy Companies Profiles
7.1 ELI Lilly
7.1.1 ELI Lilly Company Summary
7.1.2 ELI Lilly Business Overview
7.1.3 ELI Lilly Cancer Biological Therapy Major Product Offerings
7.1.4 ELI Lilly Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.1.5 ELI Lilly Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Cancer Biological Therapy Major Product Offerings
7.2.4 Sanofi Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Cancer Biological Therapy Major Product Offerings
7.3.4 Merck Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Cancer Biological Therapy Major Product Offerings
7.4.4 Bayer Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Cancer Biological Therapy Major Product Offerings
7.5.4 Roche Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Novartis International
7.6.1 Novartis International Company Summary
7.6.2 Novartis International Business Overview
7.6.3 Novartis International Cancer Biological Therapy Major Product Offerings
7.6.4 Novartis International Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.6.5 Novartis International Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Cancer Biological Therapy Major Product Offerings
7.7.4 Pfizer Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Cancer Biological Therapy Major Product Offerings
7.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Seattle Genetics
7.9.1 Seattle Genetics Company Summary
7.9.2 Seattle Genetics Business Overview
7.9.3 Seattle Genetics Cancer Biological Therapy Major Product Offerings
7.9.4 Seattle Genetics Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.9.5 Seattle Genetics Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Cancer Biological Therapy Major Product Offerings
7.10.4 Amgen Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 Takeda Pharmaceuticals
7.11.1 Takeda Pharmaceuticals Company Summary
7.11.2 Takeda Pharmaceuticals Business Overview
7.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Major Product Offerings
7.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.11.5 Takeda Pharmaceuticals Key News & Latest Developments
7.12 GlaxoSmithKline
7.12.1 GlaxoSmithKline Company Summary
7.12.2 GlaxoSmithKline Business Overview
7.12.3 GlaxoSmithKline Cancer Biological Therapy Major Product Offerings
7.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.12.5 GlaxoSmithKline Key News & Latest Developments
7.13 Spectrum Pharmaceuticals
7.13.1 Spectrum Pharmaceuticals Company Summary
7.13.2 Spectrum Pharmaceuticals Business Overview
7.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Major Product Offerings
7.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.13.5 Spectrum Pharmaceuticals Key News & Latest Developments
7.14 Celgene Corporation
7.14.1 Celgene Corporation Company Summary
7.14.2 Celgene Corporation Business Overview
7.14.3 Celgene Corporation Cancer Biological Therapy Major Product Offerings
7.14.4 Celgene Corporation Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.14.5 Celgene Corporation Key News & Latest Developments
7.15 AstraZeneca, Plc.
7.15.1 AstraZeneca, Plc. Company Summary
7.15.2 AstraZeneca, Plc. Business Overview
7.15.3 AstraZeneca, Plc. Cancer Biological Therapy Major Product Offerings
7.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.15.5 AstraZeneca, Plc. Key News & Latest Developments
7.16 Otsuka
7.16.1 Otsuka Company Summary
7.16.2 Otsuka Business Overview
7.16.3 Otsuka Cancer Biological Therapy Major Product Offerings
7.16.4 Otsuka Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.16.5 Otsuka Key News & Latest Developments
7.17 Eisai
7.17.1 Eisai Company Summary
7.17.2 Eisai Business Overview
7.17.3 Eisai Cancer Biological Therapy Major Product Offerings
7.17.4 Eisai Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.17.5 Eisai Key News & Latest Developments
7.18 Abbvie
7.18.1 Abbvie Company Summary
7.18.2 Abbvie Business Overview
7.18.3 Abbvie Cancer Biological Therapy Major Product Offerings
7.18.4 Abbvie Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.18.5 Abbvie Key News & Latest Developments
7.19 Incyte
7.19.1 Incyte Company Summary
7.19.2 Incyte Business Overview
7.19.3 Incyte Cancer Biological Therapy Major Product Offerings
7.19.4 Incyte Cancer Biological Therapy Revenue in Global Market (2018-2023)
7.19.5 Incyte Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Biological Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Biological Therapy Market Drivers in Global Market
Table 3. Cancer Biological Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Biological Therapy in Global Market
Table 5. Top Cancer Biological Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Biological Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Biological Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Biological Therapy Product Type
Table 9. List of Global Tier 1 Cancer Biological Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biological Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Biological Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Biological Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Biological Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Biological Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Biological Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Biological Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Biological Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Biological Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Biological Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Biological Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Biological Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Biological Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Biological Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Biological Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Biological Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Biological Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Biological Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Biological Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Biological Therapy Revenue, (US$, Mn), 2024-2029
Table 30. ELI Lilly Company Summary
Table 31. ELI Lilly Cancer Biological Therapy Product Offerings
Table 32. ELI Lilly Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. ELI Lilly Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Cancer Biological Therapy Product Offerings
Table 36. Sanofi Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Cancer Biological Therapy Product Offerings
Table 40. Merck Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Cancer Biological Therapy Product Offerings
Table 44. Bayer Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Cancer Biological Therapy Product Offerings
Table 48. Roche Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Novartis International Company Summary
Table 51. Novartis International Cancer Biological Therapy Product Offerings
Table 52. Novartis International Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis International Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Cancer Biological Therapy Product Offerings
Table 56. Pfizer Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Bristol-Myers Squibb Company Summary
Table 59. Bristol-Myers Squibb Cancer Biological Therapy Product Offerings
Table 60. Bristol-Myers Squibb Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol-Myers Squibb Key News & Latest Developments
Table 62. Seattle Genetics Company Summary
Table 63. Seattle Genetics Cancer Biological Therapy Product Offerings
Table 64. Seattle Genetics Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Seattle Genetics Key News & Latest Developments
Table 66. Amgen Company Summary
Table 67. Amgen Cancer Biological Therapy Product Offerings
Table 68. Amgen Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Amgen Key News & Latest Developments
Table 70. Takeda Pharmaceuticals Company Summary
Table 71. Takeda Pharmaceuticals Cancer Biological Therapy Product Offerings
Table 72. Takeda Pharmaceuticals Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Takeda Pharmaceuticals Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline Cancer Biological Therapy Product Offerings
Table 76. GlaxoSmithKline Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. Spectrum Pharmaceuticals Company Summary
Table 79. Spectrum Pharmaceuticals Cancer Biological Therapy Product Offerings
Table 80. Spectrum Pharmaceuticals Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Spectrum Pharmaceuticals Key News & Latest Developments
Table 82. Celgene Corporation Company Summary
Table 83. Celgene Corporation Cancer Biological Therapy Product Offerings
Table 84. Celgene Corporation Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Celgene Corporation Key News & Latest Developments
Table 86. AstraZeneca, Plc. Company Summary
Table 87. AstraZeneca, Plc. Cancer Biological Therapy Product Offerings
Table 88. AstraZeneca, Plc. Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. AstraZeneca, Plc. Key News & Latest Developments
Table 90. Otsuka Company Summary
Table 91. Otsuka Cancer Biological Therapy Product Offerings
Table 92. Otsuka Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Otsuka Key News & Latest Developments
Table 94. Eisai Company Summary
Table 95. Eisai Cancer Biological Therapy Product Offerings
Table 96. Eisai Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Eisai Key News & Latest Developments
Table 98. Abbvie Company Summary
Table 99. Abbvie Cancer Biological Therapy Product Offerings
Table 100. Abbvie Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 101. Abbvie Key News & Latest Developments
Table 102. Incyte Company Summary
Table 103. Incyte Cancer Biological Therapy Product Offerings
Table 104. Incyte Cancer Biological Therapy Revenue (US$, Mn) & (2018-2023)
Table 105. Incyte Key News & Latest Developments
List of Figures
Figure 1. Cancer Biological Therapy Segment by Type in 2022
Figure 2. Cancer Biological Therapy Segment by Application in 2022
Figure 3. Global Cancer Biological Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Biological Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Biological Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Biological Therapy Revenue in 2022
Figure 8. By Type - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Biological Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Biological Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 16. US Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 28. China Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Biological Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Biological Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. ELI Lilly Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis International Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol-Myers Squibb Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Seattle Genetics Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Amgen Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Takeda Pharmaceuticals Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. GlaxoSmithKline Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Spectrum Pharmaceuticals Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Celgene Corporation Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. AstraZeneca, Plc. Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Otsuka Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Eisai Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Abbvie Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Incyte Cancer Biological Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
